This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Talanx Balance Sheet Health

Financial Health criteria checks 4/6

Talanx has a total shareholder equity of €13.8B and total debt of €6.8B, which brings its debt-to-equity ratio to 49%. Its total assets and total liabilities are €196.0B and €182.1B respectively. Talanx's EBIT is €2.6B making its interest coverage ratio 19.8. It has cash and short-term investments of €4.4B.

Key information

49.0%

Debt to equity ratio

€6.78b

Debt

Interest coverage ratio19.8x
Cash€4.44b
Equity€13.84b
Total liabilities€182.11b
Total assets€195.95b

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: TLXC's short term assets (€28.3B) exceed its short term liabilities (€21.7B).

Long Term Liabilities: TLXC's short term assets (€28.3B) do not cover its long term liabilities (€160.4B).


Debt to Equity History and Analysis

Debt Level: TLXC's net debt to equity ratio (17%) is considered satisfactory.

Reducing Debt: TLXC's debt to equity ratio has increased from 23.9% to 49% over the past 5 years.

Debt Coverage: TLXC's debt is well covered by operating cash flow (91.2%).

Interest Coverage: TLXC's interest payments on its debt are well covered by EBIT (19.8x coverage).


Balance Sheet


Discover healthy companies